Walk-ins Welcome
Walk-ins Welcome
INSURANCE PARTNERS
Our first class, on site billing team is readily available for patient or clinician questions.
Provider networks allow health plans to select providers that meet certain standards to be a part of their networks. This helps to ensure that consumers have access to high quality and effective care. PCG Molecular has successfully partnered as an in-network provider with the extensive list of health plan networks.
preventive care innovation
reinventing the way we approach health care
preventive care innovation
reinventing the way we approach health care
preventive care innovation
reinventing the way we approach health care
preventive care innovation
reinventing the way we approach health care
LabFinder Launches New Partnership with PG Molecular To Offer
Innovative New Tests to Network
The collaboration furthers LabFinder's mission of empowering consumers to take control of their preventative health
NEW YORK, NY, May 5, 2022 (Newswire.com) - Today, LabFinder, the digital platform that empowers
consumers to find in-network doctors, labs and imaging centers, schedule diagnostic tests, and view and
store test results, announced the expansion of its lab test offering through a partnership with PCG
Molecular. The Atlanta-based preventive care diagnostic company is dedicated to the research and
development of genetic, molecular screens to facilitate early detection of health issues and provide
practitioners with solutions for managing disease.
The partnership will allow LabFinder to expand its test offerings to include PCG Molecular's suite of
innovative new tests, first in the Atlanta market and then nationally.
"Today, healthcare consumers are more involved in their medical decision-making than ever before.
COVID-19 has disrupted the traditional 'go-to-the-doctor' model, and empowered people to manage their
own preventative health, antigen and genetic testing," said Armando Moncada, MD FCAP and Chief
Executive Officer of PCG Molecular. "In LabFinder, we have found a partner that has an incredible staff and
business model that will allow our organizations to innovate the world of direct-to-consumer testing,
providing individuals with the resources to take important preventative measures in their health care."
"LabFinder strongly believes the technology-centered relationship between our organization and PCG
Molecular is the next step forward in developing nationwide, test-to-treat protocols that will enhance
preventative care for generations to come," said Dr. Robert Segal, MD, the CEO, and co-founder of
LabFinder." LabFinder's mission is to empower patients to access the care they deserve and become
advocates for their own health. PCG Molecular's extensive suite of medical testing and their advancement
of healthcare products currently in the research and development phases aligns strongly with our
organizational purpose. We're excited to see where this partnership will take us."
For more information about LabFinder's services visit labfinder.com.